Position statement: National Gaucher Foundation Medical Advisory Board, January 7, 2014-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Position statement: National Gaucher Foundation Medical Advisory Board, January 7, 2014

Published:2014-03-07 Issue:5 Volume:89 Page:457-458
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Barranger John A.¹,Brady Roscoe O.²,Grabowski Gregory A.³,Mankin Henry⁴,Mistry Pramod K.⁵,Weinreb Neal J.⁶

Affiliation:

1. Lysosomal Storage Disease Clinical Care Network; Pittsburgh PA

2. Surgical Neurology Branch; NINDS, NIH Bethesda MD

3. Synageva BioPharma; Lexington MA

4. Department of Orthopedic Surgery; Massachusetts General Hospital; Boston MA

5. Yale University School of Medicine; New Haven CT

6. University Research Foundation for Lysosomal Storage Diseases; Coral Springs FL

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.23687/fullpdf

Reference31 articles.

1. Characterization of gene-activated human acid-beta-glucosidase: Crystal structure, glycan composition, and internalization into macrophages;Brumshtein;Glycobiology,2010

2. Glycosylation and functionality of recombinant β-glucocerebrosidase from various production systems;Tekoah;Biosci Rep,2013

3. Enzyme therapy in type 1 Gaucher disease: Comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources;Grabowski;Ann Intern Med,1995

4. Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: A report from the Gaucher Registry;Weinreb;Am J Med,2002

5. Long-term clinical outcomes in type 1 Gaucher disease following 10 years of imiglucerase treatment;Weinreb;J Inherit Metab Dis,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osteonecrosis in Gaucher disease in the era of multiple therapies: Biomarker set for risk stratification from a tertiary referral center;eLife;2023-05-30

2. Osteonecrosis in Gaucher Disease in the era of multiple therapies: biomarker set for risk stratification from a tertiary referral center;2023-03-27

3. Healthcare resource utilization and cost of care for Gaucher patients in Iran;Journal of Diabetes & Metabolic Disorders;2019-04-09

4. The Clinical Efficacy of Imiglucerase versus Eliglustat in Patients with Gaucher's Disease Type 1;Journal of Research in Pharmacy Practice;2018-10

5. The clinical efficacy of imiglucerase versus eliglustat in patients with Gaucher's disease Type 1: A systematic review;Journal of Research in Pharmacy Practice;2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3